目次

Chapter- 1: Introduction
Study Goals and Objectives
Scope of Report
Methodology
Information Sources
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports

Chapter- 2: Summary and Highlights
Table 0A : Global Market for Immunotherapy Drugs, by Product Type, Through 2025
Figure 0A : Global Market for Immunotherapy Drugs, by Product Type, 2019-2025
Table 0B : Global Market for Immunotherapy Drugs, by Region, Through 2025
Figure 0B : Global Market for Immunotherapy Drugs, by Region, 2019-2025

Chapter- 3: Market and Technology Background
Immunotherapy
Towards Combination Immunotherapy
Focusing on Cell-mediated Adaptive Immunity
Fine Tuning Vs. Boosting Cancer Immunity
Early Vs. Advanced Stage Cancer Immunotherapy
Personalized Treatment Paradigm
Clinically Significant Types of Cancers
Future of Immunotherapy in Cancer
Infectious Diseases
Immunotherapy against Autoimmune Disorders
Immunotherapies against Infectious Diseases
Biologics as Autoimmune Disorder Therapies
Trends in Autoimmune Disorder Therapies
Types of Immunotherapies

Chapter- 4: Market Dynamics
Strengths of Immunotherapy Market
Weaknesses of the Immunotherapy Market
Threats to Immunotherapy Market
Opportunities in the Immunotherapy Market
Figure 25 : SWOT Analysis of Immunotherapy Market

Chapter- 5: Impact of COVID-19 on the Pharmaceutical Industry
Short-term Impact
Long-term Impact
Figure 26 : Impact of COVID-19 on the Pharmaceutical Industry

Chapter- 6: Market Breakdown by Product Type
Overview
Monoclonal Antibodies
Market by Region
Checkpoint Inhibitors
Nivolumab (Opdivo)
Atezolizumab (Tecentriq)
Avelumab (Bavencio)
Durvalumab (Imfinzi)
Market by Region
Interferons and Interleukins
Market by Region
Market by Disease Area

Chapter- 7: Market Breakdown by Region
Market Overview and Discussion
North America
Europe
Asia-Pacific
Rest of the World

Chapter- 8: Company Profiles
ABBVIE INC.
AMGEN INC.
ASTRAZENECA
BAYER AG
BRISTOL MYERS SQUIBB
F. HOFFMANN-LA ROCHE LTD.
JOHNSON & JOHNSON
VIATRIS INC. (FORMERLY MYLAN)
NOVARTIS AG
PFIZER INC.
VERTEX PHARMACEUTICALS INC.